This peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.
Aadel Chaudhuri, MD, PhD
Advertisement
Articles by Aadel Chaudhuri, MD, PhD
Advertisement
Latest Updated Articles
ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation TherapyPublished: November 14th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
3
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
4
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
5
